
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Nanotherapeutics in Cancer Vaccination and Challenges consolidates the current research on cancer nanomedicine and therapeutic cancer vaccination to explore the most effective and promising avenues. The book covers cancer vaccines before exploring nanotherapeutics, DNA and mRNA vaccines in cancer treatment. Finally, it considers regulatory and industrial perspectives on cancer vaccination and nanotherapeutics. This resource will be useful for pharmaceutical scientists and researchers focused on biomedical engineering, chemical engineering, vaccine development, and cancer immunotherapy, along with advanced students in these subjects. Cancer is arguably the most complex and challenging disease known to mankind. Over the last two-decades, significant advancements have been made in new and novel concepts of cancer nanomedicines. Therapeutic cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumors that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. Presents the progress made in cancer medicines from conventional to targeted therapy Covers the present state-of-the-art of cancer nanomedicines and upcoming therapeutic cancer vaccination Contains a focus on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, siRNA
This book investigates the intersection of nanotherapeutics and cancer vaccination to identify the most promising strategies for combating cancer. It consolidates current research, beginning with an overview of cancer vaccines before delving into nanotherapeutics, including DNA and mRNA vaccines. The work also addresses the crucial regulatory and industrial considerations for implementing these advanced treatments, making it a valuable resource for scientists, engineers, and students in related fields.
The book is presented as a consolidation of current research for professionals and advanced students in fields like pharmaceutical science, biomedical engineering, and vaccine development. It aims to cover the progress from conventional to targeted cancer therapies, with a specific focus on nanomedicines and therapeutic cancer vaccination. The content is structured to provide a state-of-the-art overview and explore future avenues in cancer treatment.
Page Count:
494
Publication Date:
2022-03-08
Publisher:
Elsevier Science
ISBN-10:
0128236868
ISBN-13:
9780128236864
No comments yet. Be the first to share your thoughts!